Clinical nutrition products include clinical foods and dietary supplements that are categorized primarily as pharmaceuticals and are delivered through enteral and parenteral feeding. They are aimed at treating metabolic disorders, eating or nutritional disorders and others. The clinical nutrition market majorly comprises the geriatric population with weak digestive systems. There is also a good demand for clinical foods for the pediatric population as well.
Europe Clinical Nutrition Market-Market Dynamics
The European clinical nutrition market is driven by the aging population and increased disease diagnosis like cardiovascular diseases, cancer, dementia, and diabetes. Other factors affecting the growth of the market are increased preterm birth rates in high-income countries. However, the market is highly constrained due to the strict FDA regulations and the lack of public awareness on the importance of nutrition. The European clinical nutrition market is growing due to the increased levels of health consciousness among the population. The current trend of mergers and acquisitions between companies offers better opportunities in the market. However, the market is challenged by pricing pressures, competition, and market complexity.
The European clinical nutrition market can be segmented by the type of end-user: infant, child, adult; application: sports nutrition and therapeutic nutrition; ingredients: vitamins, amino acids, minerals and glucose; therapeutic application: diarrhea, cancer, diabetes, renal diseases, and others; and the route of administration: oral, enteral and parenteral.
The European clinical nutrition market has also been geographically segmented into the Benelux, UK, France, Germany, Italy, Spain, Portugal, and Scandinavia, with the UK dominating the European market. France is also an emerging market that has a scope for growth and can potentially dominate the market in the future.
Market analysis for the European clinical nutrition market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the European clinical nutrition market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Characterization
5.1 Current Market Scenario
5.2 Market Overview
5.3 Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis
5.3.1 Market Drivers
220.127.116.11 Ageing Demographic
18.104.22.168 Increasing Incidence of Chronic and Lifestyle-Related Diseases
22.214.171.124 Significant Incidence of Malnutrition
5.3.2 Market Restraints
126.96.36.199 FDA Regulations
188.8.131.52 Lack of Public Awareness
5.3.3 Market Challenges
184.108.40.206 Pricing Pressures
220.127.116.11 Market Complexity
5.3.4 Market Opportunities
18.104.22.168 Increased levels of health consciousness
22.214.171.124 Mergers and Acquisitions
5.4 Clinical Nutrition Market Segmentation
5.4.1 By Applications
126.96.36.199 Sports Nutrition
188.8.131.52 Therapeutic Nutrition
5.4.2 By Ingredients
184.108.40.206 Vitamins & Amino acids
5.4.3 By Applications
220.127.116.11 Protein Maldigestion
18.104.22.168 Food allergies
22.214.171.124 Short-bowel syndrome
126.96.36.199 GI-tract impairment
188.8.131.52 Acute lung injury( ALI)
184.108.40.206 Acute Respiratory Distress( ARDS)
5.4.4 By Route of Administration
5.4.5 By Geography
220.127.116.11.5 Spain & Portugal
18.104.22.168.7 United Kingdom
5.5 Industry Analysis
5.5.1 Key Trends and Developments
5.5.2 Investment Analysis
5.5.3 PorterFive Forces
22.214.171.124 Bargaining Power of Suppliers
126.96.36.199 Bargaining Power of Consumers
188.8.131.52 Threat of New Entrants
184.108.40.206 Threat of Substitute Products and Services
220.127.116.11 Competitive Rivalry within the Industry
5.6 Competitive Landscape
5.6.1 Key Market Players
18.104.22.168 Abbott Healthcare
22.214.171.124.1 Abbott Healthcare- Business Overview
126.96.36.199.2 Abbott Healthcare- Product and Services Portfolio
188.8.131.52.3 Abbott Healthcare- Deals Landscape
184.108.40.206.4 Abbott Healthcare- SWOT Analysis
220.127.116.11 Nestle Health Sciences
18.104.22.168 Danone medical Nutrition
22.214.171.124 Fresenius Kabi
5.6.2 Merger and Acquisition Analysis
5.6.3 New Product Launches
5.6.4 Agreements, Collaborations & Partnerships
5.7 Analyst Outlook for Investment Opportunities
5.8 Future Outlook of the Market